Title:
PYRAZINE DERIVATIVE AS RET INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2020/083311
Kind Code:
A1
Abstract:
Disclosed are a series of compounds with a pyrazine structure, and the use of same in the preparation of a RET kinase inhibitor. Specifically, disclosed is a compound as shown in formula (I) or a pharmaceutically acceptable salt thereof.
Inventors:
FU ZHIFEI (CN)
LUO MIAORONG (CN)
ZHANG YANG (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
LUO MIAORONG (CN)
ZHANG YANG (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2019/112757
Publication Date:
April 30, 2020
Filing Date:
October 23, 2019
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D403/14; A61K31/4418; A61P35/00
Domestic Patent References:
WO2017161269A1 | 2017-09-21 | |||
WO2018017983A1 | 2018-01-25 |
Foreign References:
CN107250110A | 2017-10-13 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: OIL SUPPLY MECHANISM OF ROTARY MACHINE AND ROTARY MACHINE
Next Patent: COUNTERWEIGHT, COUNTERWEIGHT ASSEMBLY AND SCROLL COMPRESSOR
Next Patent: COUNTERWEIGHT, COUNTERWEIGHT ASSEMBLY AND SCROLL COMPRESSOR